1 | D mannose | - | - | - | - | 1件: 13 13 💬
|
2 | D-A-tocopheryl PEG 1000 succinate | - | - | - | - | 1件: 299 299 💬
|
3 | D-aspartate | - | - | - | - | 1件: 13 13 💬
|
4 | D-biotin | - | - | - | - | 3件: 10 10, 13, 20 💬
|
5 | D-biotina | - | - | - | - | 1件: 13 13 💬
|
6 | D-cura | - | - | - | - | 1件: 96 96 💬
|
7 | D-cure | - | - | - | - | 1件: 228 228 💬
|
8 | D-FI | 1件: Dabocemagene autoficel Dabocemagene autoficel | - | - | - | 1件: 36 36 💬
|
9 | D-galactose | - | - | - | - | 1件: 222 222 💬
|
10 | D-glucitol | 1件: Sorbitol Sorbitol | 1件: Sorbitol solution
Sorbitol solution
💬
| - | - | 1件: 28 28 💬
|
11 | D-glucose | 1件: D-glucose D-glucose | - | - | - | 2件: 86 86, 88 💬
|
12 | D-methylphenidate | - | - | - | - | 1件: 84 84 💬
|
13 | D-penicillamine | - | - | - | - | 1件: 171 171 💬
|
14 | D-penicillamine 150MG | 1件: Penicillamine Penicillamine | 1件: Penicillamine
Penicillamine
💬
| - | - | 1件: 171 171 💬
|
15 | D-penicillamine 250 MG | 1件: Penicillamine Penicillamine | 1件: Penicillamine
Penicillamine
💬
| - | - | 1件: 171 171 💬
|
16 | D-phenylalanyl-L-H | - | - | - | - | 1件: 77 77 💬
|
17 | D-phenylalanyl-L-HE | - | - | - | - | 1件: 77 77 💬
|
18 | D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-trypto | - | - | - | - | 1件: 77 77 💬
|
19 | D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophan | - | - | - | - | 1件: 77 77 💬
|
20 | D-phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemiscystyl-L-threonino | - | - | - | - | 1件: 77 77 💬
|
21 | D-serine | 1件: D-Serine D-Serine | - | - | - | 1件: 6 6 💬
|
22 | D-sorbitol | 1件: Sorbitol Sorbitol | 1件: Sorbitol solution
Sorbitol solution
💬
| - | - | 1件: 10 10 💬
|
23 | D-xylose | - | - | - | - | 1件: 98 98 💬
|
24 | D.3.6.2 - dose massima specificare: giornaliera | - | - | - | - | 1件: 86 86 💬
|
25 | D.3.6.2.1 - valore: 45 / 0.45 MG/ML | - | - | - | - | 1件: 97 97 💬
|
26 | D2e7 | - | - | - | - | 1件: 46 46 💬
|
27 | D5W | - | - | - | - | 1件: 222 222 💬
|
28 | D6-25-hydroxyvitamin D3 | - | - | - | - | 1件: 299 299 💬
|
29 | D9421-C | - | - | - | - | 1件: 96 96 💬
|
30 | D9421-C capsule 3 MG | - | - | - | - | 1件: 96 96 💬
|
31 | D9421-C, 15MG | - | - | - | - | 1件: 96 96 💬
|
32 | D9421-C, 9MG | - | - | - | - | 1件: 96 96 💬
|
33 | DA-9701 | - | - | - | - | 1件: 6 6 💬
|
34 | DA-9805 45MG | - | - | - | - | 1件: 6 6 💬
|
35 | DA-9805 90MG | - | - | - | - | 1件: 6 6 💬
|
36 | Daaoi-P | - | - | - | - | 1件: 6 6 💬
|
37 | Dabigatran | 1件: Dabigatran Dabigatran | 1件: Dabigatran
Dabigatran
💬
| 1件: F2 F2 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 3件: 85 85, 91, 124 💬
|
38 | Dabigatran etexilate | 2件: Dabigatran Dabigatran, Dabigatran etexilate | 3件: Dabigatran etexilate mesylate
Dabigatran etexilate mesylate
,
Dabigatran etexilate
,
Dabigatran
💬
| 1件: F2 F2 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 2件: 51 51, 75 💬
|
39 | Dabrafenib | 1件: Dabrafenib Dabrafenib | 2件: Dabrafenib
Dabrafenib
,
Dabrafenib mesylate
💬
| 1件: BRAF BRAF 💬
| 42件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Bladder cancer, Breast cancer, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Renal cell carcinoma, Serotonergic synapse, Thyroid cancer, Vascular smooth muscle contraction, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 💬
|
40 | Dabu ying pills | - | - | - | - | 1件: 76 76 💬
|
41 | DAC HYP | - | - | - | - | 1件: 13 13 💬
|
42 | DAC-HYP | - | - | - | - | 1件: 13 13 💬
|
43 | Dacepton 5 MG/ML infuusioneste, liuos | - | - | - | - | 1件: 6 6 💬
|
44 | Daclizumab | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 💬
|
45 | Daclizumab high yield process | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
46 | Daclizumab HYP | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
47 | Daclizumab HYP (DAC HYP | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
48 | Daclizumab HYP (DAC HYP) | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
49 | Daclizumab with greek suufix | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
50 | Dacortin | - | - | - | - | 2件: 97 97, 162 💬
|
51 | DacortíN 2,5MG | - | - | - | - | 1件: 222 222 💬
|
52 | DacortíN 30MG | - | - | - | - | 1件: 222 222 💬
|
53 | DacortíN 5MG | - | - | - | - | 1件: 222 222 💬
|
54 | Daily ingestion OF lactobacillus plantarum PS128 | - | - | - | - | 1件: 6 6 💬
|
55 | Dalacin C phosphate | 1件: Clindamycin Clindamycin | 4件: Clindamycin
Clindamycin
,
Clindamycin phosphate
,
Clindamycin palmitate hydrochloride
,
Clindamycin hydrochloride
💬
| - | - | 1件: 46 46 💬
|
56 | Dalfampridine | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 4 4, 13 💬
|
57 | Dalfampridine ER | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
58 | Dalfampridine ER, 10 MG oral tablet, extended release | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
59 | Dalfampridine plus physical therapy | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
60 | Dalfampridine-ER 10MG | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
61 | Dalfampridine-ER 5MG | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
62 | Dalteparin | 1件: Dalteparin Dalteparin | 1件: Dalteparin sodium
Dalteparin sodium
💬
| 1件: SERPINC1 SERPINC1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 222 222 💬
|
63 | Danazol | 1件: Danazol Danazol | 1件: Danazol
Danazol
💬
| 3件: AR AR, ESR1, PGR 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 5件: 60 60, 63, 64, 65, 285 💬
|
64 | Dandshen | - | - | - | - | 1件: 222 222 💬
|
65 | Danicopan | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 2件: 62 62, 222 💬
|
66 | Dantrolene | 1件: Dantrolene Dantrolene | 2件: Dantrolene sodium
Dantrolene sodium
,
Dantrolene
💬
| - | - | 1件: 13 13 💬
|
67 | Dantrolene sodium | 1件: Dantrolene Dantrolene | 2件: Dantrolene sodium
Dantrolene sodium
,
Dantrolene
💬
| - | - | 1件: 233 233 💬
|
68 | Danzhu fuyuan granule | - | - | - | - | 1件: 222 222 💬
|
69 | Dapagliflozin | 1件: Dapagliflozin Dapagliflozin | 1件: Dapagliflozin
Dapagliflozin
💬
| - | - | 10件: 6 6, 28, 49, 66, 67, 86, 88, 215, 218, 222 💬
|
70 | Dapagliflozin 10MG TAB | 1件: Dapagliflozin Dapagliflozin | 1件: Dapagliflozin
Dapagliflozin
💬
| - | - | 3件: 19 19, 97, 218 💬
|
71 | Dapagliflozin tablet | 1件: Dapagliflozin Dapagliflozin | 1件: Dapagliflozin
Dapagliflozin
💬
| - | - | 1件: 210 210 💬
|
72 | Dapirolizumab pegol | 1件: Dapirolizumab pegol Dapirolizumab pegol | - | - | - | 2件: 13 13, 49 💬
|
73 | Dapsone | 1件: Dapsone Dapsone | 1件: Dapsone
Dapsone
💬
| - | - | 5件: 35 35, 42, 60, 84, 162 💬
|
74 | Dara IV | - | - | - | - | 1件: 28 28 💬
|
75 | Dara SC | - | - | - | - | 1件: 28 28 💬
|
76 | Daraprim | 1件: Pyrimethamine Pyrimethamine | 1件: Pyrimethamine
Pyrimethamine
💬
| - | - | 2件: 2 2, 4 💬
|
77 | Daratumumab | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 7件: 13 13, 28, 46, 48, 49, 60, 63 💬
|
78 | Daratumumab and corticosteroid treatment | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 288 288 💬
|
79 | Daratumumab and hyaluronidase-fihj | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 💬
|
80 | Daratumumab and pomalidomide | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 💬
|
81 | Daratumumab injection | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 4件: 16 16, 28, 49, 63 💬
|
82 | Daratumumab SC | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 2件: 28 28, 331 💬
|
83 | Daratumumab/daratumumab and hyaluronidase-fihj | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 💬
|
84 | Darifenacin | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 13 13, 26 💬
|
85 | Darifenacin 7.5 MG extended release oral tablet | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 2 2 💬
|
86 | Darunavir | 1件: Darunavir Darunavir | 3件: Darunavir
Darunavir
,
Darunavir ethanolate
,
Darunavir propylene glycolate
💬
| - | - | 1件: 2 2 💬
|
87 | Darvadstrocel | 1件: Darvadstrocel Darvadstrocel | 1件: Darvadstrocel
Darvadstrocel
💬
| - | - | 1件: 96 96 💬
|
88 | Darvocet | - | - | - | - | 1件: 70 70 💬
|
89 | Darzalex | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 3件: 28 28, 49, 63 💬
|
90 | DAS-001 | - | - | - | - | 1件: 11 11 💬
|
91 | Dasatinib | 1件: Dasatinib Dasatinib | 2件: Dasatinib
Dasatinib
,
Dasatinib
💬
| 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬
| 76件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 1件: 51 51 💬
|
92 | Dasatinib + quercetin | 1件: Dasatinib Dasatinib | 2件: Dasatinib
Dasatinib
,
Dasatinib
💬
| 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬
| 76件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 1件: 85 85 💬
|
93 | Data capture | - | - | - | - | 1件: 6 6 💬
|
94 | Data collection | - | - | - | - | 2件: 65 65, 299 💬
|
95 | Data collection FOR correlation between clinical defined and LAB defined GC responsivness | - | - | - | - | 1件: 41 41 💬
|
96 | Data collection FOR exploratory analyses OF endogenous steroid hormones | - | - | - | - | 1件: 41 41 💬
|
97 | Data collection FOR prednisone metabolism | - | - | - | - | 1件: 41 41 💬
|
98 | Data report | - | - | - | - | 1件: 162 162 💬
|
99 | Datscan | - | - | - | - | 3件: 2 2, 5, 6 💬
|
100 | Datscan 74 MBQ/ML solution FOR injection | - | - | - | - | 1件: 6 6 💬
|
101 | Datscan and spect imaging | - | - | - | - | 1件: 6 6 💬
|
102 | Davunetide | 1件: Davunetide Davunetide | 1件: Davunetide
Davunetide
💬
| - | - | 3件: 5 5, 7, 127 💬
|
103 | Daxdilimab | 1件: Daxdilimab Daxdilimab | 1件: Daxdilimab
Daxdilimab
💬
| 1件: LILR LILR 💬
| 2件: B cell receptor signaling pathway B cell receptor signaling pathway, Osteoclast differentiation 💬 | 2件: 49 49, 50 💬
|
104 | Dazarlex | - | - | - | - | 1件: 28 28 💬
|
105 | Dazodalibep | 1件: Dazodalibep Dazodalibep | - | - | - | 1件: 53 53 💬
|
106 | Dazucorilant | 1件: Dazucorilant Dazucorilant | 1件: Dazucorilant
Dazucorilant
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 💬
|
107 | Dazucorilant 150 MG | 1件: Dazucorilant Dazucorilant | 1件: Dazucorilant
Dazucorilant
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 💬
|
108 | Dazucorilant 300 MG | 1件: Dazucorilant Dazucorilant | 1件: Dazucorilant
Dazucorilant
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 💬
|
109 | Dazukibart | 1件: Dazukibart Dazukibart | 1件: Dazukibart
Dazukibart
💬
| 1件: IFNB IFNB 💬
| 28件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, RIG-I-like receptor signaling pathway, Shigellosis, TNF signaling pathway, Toll-like receptor signaling pathway, Tuberculosis, Yersinia infection 💬 | 1件: 50 50 💬
|
110 | DB adalimumab 40 MG EOW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
111 | DB adalimumab 40 MG EW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
112 | DB-2304 | - | - | - | - | 1件: 49 49 💬
|
113 | DB-3Q | - | - | - | - | 1件: 96 96 💬
|
114 | DBS setting maximizing prefrontal activation | - | - | - | - | 1件: 6 6 💬
|
115 | DBS setting minimizing prefrontal activation | - | - | - | - | 1件: 6 6 💬
|
116 | DC-TAB | - | - | - | - | 1件: 13 13 💬
|
117 | DC158AM | - | - | - | - | 1件: 6 6 💬
|
118 | Dccr | - | - | - | - | 1件: 193 193 💬
|
119 | DCI | - | - | - | - | 1件: 6 6 💬
|
120 | DCI 1020 | - | - | - | - | 1件: 299 299 💬
|
121 | DCR-1171X | - | - | - | - | 1件: 234 234 💬
|
122 | DCR-L1360 | - | - | - | - | 1件: 234 234 💬
|
123 | DCR-PH1 | 1件: DCR-PH1 DCR-PH1 | - | - | - | 1件: 234 234 💬
|
124 | DCR-phxc | - | - | - | - | 1件: 234 234 💬
|
125 | Ddavp | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 3件: 75 75, 225, 288 💬
|
126 | DE-activated smart device | - | - | - | - | 1件: 299 299 💬
|
127 | DE-implementation OF inhaled nitric oxide (INO) USE | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 1件: 294 294 💬
|
128 | Dead SEA solar and water treatment | - | - | - | - | 1件: 46 46 💬
|
129 | Deanol pyroglutamate | 1件: Deanol Deanol | 1件: Deanol
Deanol
💬
| - | - | 1件: 6 6 💬
|
130 | Deaxamethasone | - | - | - | - | 1件: 28 28 💬
|
131 | Debamestrocel | 1件: Debamestrocel Debamestrocel | - | - | - | 1件: 2 2 💬
|
132 | Debio 4126 | - | - | - | - | 1件: 77 77 💬
|
133 | Debio 4326 | - | - | - | - | 1件: 76 76 💬
|
134 | Debrumyl | - | - | - | - | 1件: 6 6 💬
|
135 | Decadron | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
136 | Decadron phosphate, injectable | - | - | - | - | 1件: 70 70 💬
|
137 | Decartes-08 | - | - | - | - | 1件: 11 11 💬
|
138 | Decitabine | 1件: Decitabine Decitabine | 1件: Decitabine
Decitabine
💬
| 3件: DNMT1 DNMT1, DNMT3A, DNMT3B 💬
| 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Efferocytosis, MicroRNAs in cancer 💬 | 2件: 60 60, 63 💬
|
139 | Decolonization | - | - | - | - | 1件: 299 299 💬
|
140 | Decortin | - | - | - | - | 2件: 46 46, 113 💬
|
141 | Decortin (prednisona) 5 MG comprimidos | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
142 | Decortin 20 MG | - | - | - | - | 1件: 96 96 💬
|
143 | Decortin 5 MG | - | - | - | - | 1件: 96 96 💬
|
144 | Decortin 5MG tablets | - | - | - | - | 1件: 46 46 💬
|
145 | Decortin H | - | - | - | - | 2件: 66 66, 145 💬
|
146 | Decortin H 1 MG | - | - | - | - | 1件: 97 97 💬
|
147 | Decortin H 10MG | - | - | - | - | 1件: 97 97 💬
|
148 | Decortin H 20MG | - | - | - | - | 1件: 97 97 💬
|
149 | Decortin H 50 MG | - | - | - | - | 1件: 97 97 💬
|
150 | Decortin H 5MG | - | - | - | - | 1件: 97 97 💬
|
151 | Decrease tocilizumab, abatacept | 2件: Abatacept Abatacept, Tocilizumab | 2件: Tocilizumab
Tocilizumab
,
Abatacept
💬
| 3件: CD80 CD80, CD86, IL6R 💬
| 24件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
152 | Dectancyl | - | - | - | - | 1件: 81 81 💬
|
153 | Deep brain stimulation | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 💬
|
154 | Defanyl 50 and 100 MG | - | - | - | - | 1件: 46 46 💬
|
155 | Deferasirox | 1件: Deferasirox Deferasirox | 1件: Deferasirox
Deferasirox
💬
| - | - | 4件: 54 54, 254, 284, 286 💬
|
156 | Deferiprone | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 7件: 2 2, 6, 18, 121, 122, 139, 233 💬
|
157 | Deferiprone 20MG | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
158 | Deferiprone 30MG | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
159 | Deferiprone 600 MG delayed release tablet | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
160 | Deferiprone 80 MG/ML oral solution | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 121 121 💬
|
161 | Deferiprone DR | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 2件: 2 2, 6 💬
|
162 | Deferiprone oral solution | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 121 121 💬
|
163 | Deferitazole | 1件: Deferitazole Deferitazole | 1件: Deferitazole
Deferitazole
💬
| - | - | 1件: 284 284 💬
|
164 | Deferoxamine | 1件: Deferoxamine Deferoxamine | 3件: Deferoxamine mesylate
Deferoxamine mesylate
,
Deferoxamine
,
Deferoxamine hydrochloride
💬
| - | - | 2件: 284 284, 286 💬
|
165 | Deferoxamine mesilate | 1件: Deferoxamine Deferoxamine | 3件: Deferoxamine mesylate
Deferoxamine mesylate
,
Deferoxamine
,
Deferoxamine hydrochloride
💬
| - | - | 1件: 286 286 💬
|
166 | Definity perflutren lipid microsphere ultrasound contrast | 1件: Perflutren Perflutren | 1件: Perflutren
Perflutren
💬
| - | - | 1件: 70 70 💬
|
167 | Deflan*10CPR 6MG | - | - | - | - | 1件: 113 113 💬
|
168 | Deflazacort | 1件: Deflazacort Deflazacort | 1件: Deflazacort
Deflazacort
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 30 30, 113 💬
|
169 | Deflazacort 6 MG tablets | 1件: Deflazacort Deflazacort | 1件: Deflazacort
Deflazacort
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
170 | Deflegmin 75MG, kapsulki O przedluzonym uwalnianiu | - | - | - | - | 1件: 19 19 💬
|
171 | Dehydrated alcohol (absolute alcohol) BP FOR injection | 1件: Ethanol Ethanol | 3件: Alcohol
Alcohol
,
Isopropanol and methylated alcohol
,
Ethanol
💬
| - | - | 1件: 279 279 💬
|
172 | Dehydrated human amnion/chorion membrane | - | - | - | - | 1件: 269 269 💬
|
173 | Dehydroepiandrosterone | 1件: Prasterone Prasterone | 1件: Prasterone
Prasterone
💬
| 3件: AR AR, ESR1, ESR2 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 4件: 49 49, 53, 83, 96 💬
|
174 | Dehydroepiandrosterone 100 and 400 MG | 1件: Prasterone Prasterone | 1件: Prasterone
Prasterone
💬
| 3件: AR AR, ESR1, ESR2 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 💬
|
175 | Dekavil | - | - | - | - | 2件: 46 46, 97 💬
|
176 | Dekristol | - | - | - | - | 1件: 97 97 💬
|
177 | Dekristol 20.000 IE | - | - | - | - | 1件: 96 96 💬
|
178 | Dekristol 20000 IE | - | - | - | - | 1件: 13 13 💬
|
179 | Dekristol® 400-tabletten | - | - | - | - | 1件: 13 13 💬
|
180 | Deksmedetomidiini | - | - | - | - | 1件: 70 70 💬
|
181 | Delandistrogene moxeparvovec | 1件: Delandistrogene moxeparvovec Delandistrogene moxeparvovec | 1件: Delandistrogene moxeparvovec
Delandistrogene moxeparvovec
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
182 | Delayed and extended release mesalazine | - | - | - | - | 1件: 97 97 💬
|
183 | Delayed release 6 mercaptopurine | - | - | - | - | 1件: 96 96 💬
|
184 | Delayed release 6MP or calcitriol VS. purinethol | - | - | - | - | 1件: 96 96 💬
|
185 | Delgocitinib | 1件: Delgocitinib Delgocitinib | 1件: Delgocitinib
Delgocitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 50 50 💬
|
186 | Deligoparin | - | - | - | - | 1件: 97 97 💬
|
187 | Delivery OF 99MTC-dtpa aerosol | - | - | - | - | 1件: 85 85 💬
|
188 | Delix | - | - | - | - | 1件: 218 218 💬
|
189 | Delmitide acetate | - | - | - | - | 1件: 97 97 💬
|
190 | Delta-9-tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 13 13, 36 💬
|
191 | Deltacortene | - | - | - | - | 2件: 43 43, 97 💬
|
192 | Deltacortene 10 CPR 25MG | - | - | - | - | 1件: 97 97 💬
|
193 | Deltacortene 20 CPR 5MG | - | - | - | - | 1件: 97 97 💬
|
194 | Deltacortene forte*10CPR 25MG | - | - | - | - | 2件: 46 46, 97 💬
|
195 | Deltacortene*10CPR 25MG | - | - | - | - | 1件: 84 84 💬
|
196 | Deltacortene*20CPR 5MG | - | - | - | - | 3件: 49 49, 97, 113 💬
|
197 | Deltacortril enteric | - | - | - | - | 1件: 46 46 💬
|
198 | Demestril septem | - | - | - | - | 1件: 13 13 💬
|
199 | Demineralized bone matrix | - | - | - | - | 1件: 70 70 💬
|
200 | Denosumab | 1件: Denosumab Denosumab | 1件: Denosumab
Denosumab
💬
| 1件: TNFSF11 TNFSF11 💬
| 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 10件: 46 46, 50, 70, 75, 77, 93, 95, 96, 274, 299 💬
|
201 | Denosumab - - immunoglobulin G2 human monoclonal antibody TO rank ligand | 1件: Denosumab Denosumab | 1件: Denosumab
Denosumab
💬
| 1件: TNFSF11 TNFSF11 💬
| 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 💬
|
202 | Denosumab - immunoglobulin G2 human monoclonal antibody TO rank ligand | 1件: Denosumab Denosumab | 1件: Denosumab
Denosumab
💬
| 1件: TNFSF11 TNFSF11 💬
| 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 💬
|
203 | Denufosol | 1件: Denufosol Denufosol | 1件: Denufosol tetrasodium
Denufosol tetrasodium
💬
| 1件: P2RY2 P2RY2 💬
| 4件: Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 💬
|
204 | Denufosol tetrasodium (INS37217) inhalation solution | 1件: Denufosol Denufosol | 1件: Denufosol tetrasodium
Denufosol tetrasodium
💬
| 1件: P2RY2 P2RY2 💬
| 4件: Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 💬
|
205 | Denufosol tetrasodium inhalation solution | 1件: Denufosol Denufosol | 1件: Denufosol tetrasodium
Denufosol tetrasodium
💬
| 1件: P2RY2 P2RY2 💬
| 4件: Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 💬
|
206 | Denusomab | - | - | - | - | 1件: 274 274 💬
|
207 | Deoxycholic acid | 1件: Deoxycholic acid Deoxycholic acid | 1件: Deoxycholic acid
Deoxycholic acid
💬
| - | - | 1件: 34 34 💬
|
208 | Depakine | - | - | - | - | 2件: 102 102, 233 💬
|
209 | Depakine chrono 500 MG | - | - | - | - | 1件: 233 233 💬
|
210 | Depakine chrono® 500 MG | - | - | - | - | 1件: 233 233 💬
|
211 | Depalgos*20+325MG 28CPR RP | - | - | - | - | 1件: 46 46 💬
|
212 | Depelestat | 1件: Depelestat Depelestat | 1件: Depelestat
Depelestat
💬
| 1件: ELANE ELANE 💬
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | 1件: 299 299 💬
|
213 | Depemedrone | - | - | - | - | 1件: 46 46 💬
|
214 | Depemokimab | 1件: Depemokimab Depemokimab | 1件: Depemokimab
Depemokimab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
215 | Depleted stem cell transplant | - | - | - | - | 1件: 285 285 💬
|
216 | Depletion OF CD3/CD19 IN AN autologous stem cell transplant | - | - | - | - | 2件: 49 49, 51 💬
|
217 | Depo medrol | - | - | - | - | 1件: 46 46 💬
|
218 | DEPO-medrol 40MG/ML suspension FOR injection | - | - | - | - | 1件: 70 70 💬
|
219 | DEPO-medrone | - | - | - | - | 1件: 46 46 💬
|
220 | Depomedrol | - | - | - | - | 1件: 70 70 💬
|
221 | Depot leuprolide acetate 3.75 MG | - | - | - | - | 1件: 51 51 💬
|
222 | Depot tetracosactide | - | - | - | - | 1件: 83 83 💬
|
223 | Deprakine | - | - | - | - | 1件: 256 256 💬
|
224 | Dermoval | - | - | - | - | 2件: 35 35, 162 💬
|
225 | Dersalazina sodica | - | - | - | - | 1件: 97 97 💬
|
226 | Dersalazine sodium | 1件: Dersalazine Dersalazine | - | - | - | 1件: 97 97 💬
|
227 | Dersimelagon | 1件: Dersimelagon Dersimelagon | 1件: Dersimelagon
Dersimelagon
💬
| 1件: MC1R MC1R 💬
| 3件: Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 2件: 51 51, 254 💬
|
228 | Desametasone | - | - | - | - | 2件: 28 28, 90 💬
|
229 | Desametasone 40MG | - | - | - | - | 1件: 63 63 💬
|
230 | Desametasone sodio fosfato | - | - | - | - | 1件: 28 28 💬
|
231 | Descartes-08 | - | - | - | - | 2件: 11 11, 49 💬
|
232 | Desert harvest aloe vera capsules | - | - | - | - | 1件: 226 226 💬
|
233 | Desferal | 1件: Deferoxamine Deferoxamine | 3件: Deferoxamine mesylate
Deferoxamine mesylate
,
Deferoxamine
,
Deferoxamine hydrochloride
💬
| - | - | 2件: 284 284, 286 💬
|
234 | Desferasirox | - | - | - | - | 1件: 60 60 💬
|
235 | Desflurane | 1件: Desflurane Desflurane | 1件: Desflurane
Desflurane
💬
| - | - | 2件: 22 22, 296 💬
|
236 | Desflurane anesthetics | 1件: Desflurane Desflurane | 1件: Desflurane
Desflurane
💬
| - | - | 1件: 296 296 💬
|
237 | Desipramine | 1件: Desipramine Desipramine | 2件: Desipramine hydrochloride
Desipramine hydrochloride
,
Desipramine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 121 121 💬
|
238 | Desloratadine given orally | 1件: Desloratadine Desloratadine | 1件: Desloratadine
Desloratadine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
239 | Desmopressin | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 3件: 64 64, 75, 288 💬
|
240 | Desmopressin acetat | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 6 6 💬
|
241 | Desmopressin acetate | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 64 64, 288 💬
|
242 | Desmopressin acetate trihydrate | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 225 225 💬
|
243 | Desmopressin intranasal | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 72 72 💬
|
244 | Desmopressin oral melt | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 72 72 💬
|
245 | Desmopressine | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 288 288 💬
|
246 | Desmopressine nasal spray 10 MG/ML, flacon 60 doses | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 225 225 💬
|
247 | Desmotabs | - | - | - | - | 1件: 6 6 💬
|
248 | Desmotabs® 0,2 MG tabletten | - | - | - | - | 1件: 6 6 💬
|
249 | Desmotabs® 0,2MG tabletten | - | - | - | - | 1件: 6 6 💬
|
250 | Desogestrel | 1件: Desogestrel Desogestrel | 1件: Desogestrel
Desogestrel
💬
| 2件: ESR1 ESR1, PGR 💬
| 11件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 230 230 💬
|
251 | Desoxyribonuclease | 1件: Desoxyribonuclease Desoxyribonuclease | - | - | - | 1件: 299 299 💬
|
252 | Determination OF calcium intake BY A dietician interview | - | - | - | - | 2件: 13 13, 46 💬
|
253 | Determination OF drug effects through amantadine cessation | - | - | - | - | 1件: 6 6 💬
|
254 | Determination OF objective and subjective pain threshold | - | - | - | - | 1件: 17 17 💬
|
255 | Detoxifying agents FOR antineoplastic treatment | - | - | - | - | 2件: 299 299, 337 💬
|
256 | Deucravacitinib | 1件: Deucravacitinib Deucravacitinib | 1件: Deucravacitinib
Deucravacitinib
💬
| 1件: TYK2 TYK2 💬
| 17件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | 9件: 36 36, 37, 49, 53, 84, 96, 97, 160, 269 💬
|
257 | Deucrictibant | 1件: Deucrictibant Deucrictibant | 1件: Deucrictibant
Deucrictibant
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
258 | Deucrictibant high dose | 1件: Deucrictibant Deucrictibant | 1件: Deucrictibant
Deucrictibant
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
259 | Deucrictibant LOW dose | 1件: Deucrictibant Deucrictibant | 1件: Deucrictibant
Deucrictibant
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
260 | Deucrictibant selected dose | 1件: Deucrictibant Deucrictibant | 1件: Deucrictibant
Deucrictibant
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
261 | Deupirfenidone | 1件: Deupirfenidone Deupirfenidone | 1件: Deupirfenidone
Deupirfenidone
💬
| - | - | 1件: 85 85 💬
|
262 | Deuterated ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
263 | Deutetrabenazine | 1件: Deutetrabenazine Deutetrabenazine | 1件: Deutetrabenazine
Deutetrabenazine
💬
| 1件: SLC18A1_2 SLC18A1_2 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 💬
|
264 | Deutivacaftor | 1件: Deutivacaftor Deutivacaftor | 1件: Deutivacaftor
Deutivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
265 | DEX 21-P | - | - | - | - | 1件: 97 97 💬
|
266 | DEX284 | - | - | - | - | 1件: 85 85 💬
|
267 | Dexa scan | - | - | - | - | 4件: 19 19, 46, 96, 299 💬
|
268 | Dexametasone | - | - | - | - | 1件: 28 28 💬
|
269 | Dexametasone fosfato sodico | - | - | - | - | 1件: 65 65 💬
|
270 | Dexametasone sodium phosphate | - | - | - | - | 2件: 96 96, 97 💬
|
271 | Dexamethason | - | - | - | - | 4件: 13 13, 28, 46, 331 💬
|
272 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 19, 28, 35, 63, 64, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
|
273 | Dexamethasone 0,1 MG tablets | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
274 | Dexamethasone 0,5MG | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬
|
275 | Dexamethasone 0.5MG tablet | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
276 | Dexamethasone 0.5MG/5ML solution | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 💬
|
277 | Dexamethasone 1,5 MG tablets | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
278 | Dexamethasone 2MG tablets | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
279 | Dexamethasone 4 MG jenapharm | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
280 | Dexamethasone 4 MG/ML injectable solution | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 💬
|
281 | Dexamethasone abcur | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
282 | Dexamethasone and rituximab | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
283 | Dexamethasone azathioprine pulse therapy | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 💬
|
284 | Dexamethasone combined with romiplostim N01 | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
285 | Dexamethasone cyclophosphamide pulse therapy | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 💬
|
286 | Dexamethasone given orally | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
287 | Dexamethasone injection | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 💬
|
288 | Dexamethasone krka | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
289 | Dexamethasone monotherapy | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
290 | Dexamethasone oral | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
291 | Dexamethasone oral, 10 MG | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
292 | Dexamethasone oral, 20 MG | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
293 | Dexamethasone palmitate | 2件: Dexamethasone Dexamethasone, Dexamethasone palmitate | 4件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone palmitate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
294 | Dexamethasone parotid irrigation | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 53 53 💬
|
295 | Dexamethasone sodium phosphate | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 65 65, 70 💬
|
296 | Dexamethasone sodium phosphate 250 MG/ 10 ML | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
297 | Dexamethasone sodium phosphate 250 MG/10 ML solution | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 💬
|
298 | Dexamethasone sodium sulfate | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
299 | Dexamethasone soduim phosphate | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
300 | Dexamethasone suppression test | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 💬
|
301 | Dexamethasone test | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 💬
|
302 | Dexamethasone USP micronized | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
303 | Dexamethasone, 40 MG | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
304 | Dexamethasone, procarbazine | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 💬
|
305 | Dexaton | - | - | - | - | 1件: 28 28 💬
|
306 | Dexchlorpheniramine | 1件: Dexchlorpheniramine Dexchlorpheniramine | 1件: Dexchlorpheniramine
Dexchlorpheniramine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
307 | Dexdor | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 4, 6, 70 💬
|
308 | Dexlansoprazole | 1件: Dexlansoprazole Dexlansoprazole | 2件: Dexlansoprazole
Dexlansoprazole
,
Dexlansoprazole sesquihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 98 98 💬
|
309 | Dexmedetomidina | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
310 | Dexmedetomidine | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
311 | Dexmedetomidine 1 | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 💬
|
312 | Dexmedetomidine 2 | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 💬
|
313 | Dexmedetomidine 3 | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 💬
|
314 | Dexmedetomidine group | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬
|
315 | Dexmedetomidine HCL 100 MCG/ML INJ | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 💬
|
316 | Dexmedetomidine hydrochloride | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬
|
317 | Dexmedetomidine hydrochloride infusion | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
318 | Dexmedetomidine injection | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬
|
319 | Dexmedetomidine with ropivacaine | 2件: Dexmedetomidine Dexmedetomidine, Ropivacaine | 4件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
,
Ropivacaine hydrochloride
,
Ropivacaine
💬
| 8件: ADRA2A ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬
|
320 | Dexpramipexole | 1件: Dexpramipexole Dexpramipexole | 1件: Dexpramipexole
Dexpramipexole
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
321 | Dexpramipexole dichydrochloride | 1件: Dexpramipexole Dexpramipexole | 1件: Dexpramipexole
Dexpramipexole
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
322 | Dexpramipexole dihydrochloride | 1件: Dexpramipexole Dexpramipexole | 1件: Dexpramipexole
Dexpramipexole
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
323 | Dexrazoxane | 1件: Dexrazoxane Dexrazoxane | 2件: Dexrazoxane
Dexrazoxane
,
Dexrazoxane hydrochloride
💬
| - | - | 1件: 13 13 💬
|
324 | Dexterity | - | - | - | - | 1件: 6 6 💬
|
325 | Dextran | 1件: Dextran Dextran | 5件: Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| 2件: LIPC LIPC, LPL 💬
| 4件: Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | 1件: 2 2 💬
|
326 | Dextran 1 FOR injection | 2件: Dextran Dextran, Dextran 1 | 5件: Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| 2件: LIPC LIPC, LPL 💬
| 4件: Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | 1件: 97 97 💬
|
327 | Dextran sulfate adsorption | 1件: Dextran Dextran | 5件: Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| 2件: LIPC LIPC, LPL 💬
| 4件: Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | 1件: 79 79 💬
|
328 | Dextran sulfate sodium | 1件: Dextran Dextran | 5件: Dextran 1
Dextran 1
,
Dextran sulfate sodium
,
Dextran 40
,
Dextran 70
,
Dextran 75
💬
| 2件: LIPC LIPC, LPL 💬
| 4件: Alzheimer disease Alzheimer disease, Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway 💬 | 1件: 2 2 💬
|
329 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 6 6, 8, 13, 21, 85, 96, 97, 156 💬
|
330 | Dextromethorphan 30 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 96 96, 97 💬
|
331 | Dextromethorphan HBR and quinidine sulfate | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
332 | Dextromethorphan hydrobromide | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 13 13, 46 💬
|
333 | Dextromethorphan hydrobromide 20 MG and quinidine sulfate 10 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 2 2, 13 💬
|
334 | Dextromethorphan hydrobromide 30 MG and quinidine sulfate 10 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 2 2, 13 💬
|
335 | Dextromethorphan/quinidine | 2件: Dextromethorphan Dextromethorphan, Quinidine | 7件: Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Daunorubicin
,
Quinidine
💬
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬
| 23件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
336 | Dextrometorfano hidrobromuro | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
337 | Dextrometorfano/quinidina | 2件: Dextromethorphan Dextromethorphan, Quinidine | 7件: Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Daunorubicin
,
Quinidine
💬
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬
| 23件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
338 | Dextrose | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 4件: 56 56, 60, 201, 226 💬
|
339 | Dextrose 50% intravenous solution | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 1件: 168 168 💬
|
340 | Dextrose, 5% IN water | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 1件: 65 65 💬
|
341 | Dezamizumab | 1件: Dezamizumab Dezamizumab | 1件: Dezamizumab
Dezamizumab
💬
| - | - | 1件: 28 28 💬
|
342 | Dezocine | 1件: Dezocine Dezocine | 1件: Dezocine
Dezocine
💬
| 2件: OPRK1 OPRK1, OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
343 | DF2156A | - | - | - | - | 1件: 162 162 💬
|
344 | DFO | - | - | - | - | 2件: 284 284, 286 💬
|
345 | DFT383 | - | - | - | - | 1件: 19 19 💬
|
346 | DFV890 | 1件: DFV890 DFV890 | - | - | - | 1件: 106 106 💬
|
347 | DG3173 | - | - | - | - | 1件: 77 77 💬
|
348 | DHA | - | - | - | - | 4件: 6 6, 46, 94, 299 💬
|
349 | DHC | - | - | - | - | 1件: 310 310 💬
|
350 | Dhea | 1件: Prasterone Prasterone | 1件: Prasterone
Prasterone
💬
| 3件: AR AR, ESR1, ESR2 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 49 49, 96 💬
|
351 | Dhea tablet | 1件: Prasterone Prasterone | 1件: Prasterone
Prasterone
💬
| 3件: AR AR, ESR1, ESR2 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 86 86 💬
|
352 | DI-17e6 | - | - | - | - | 1件: 51 51 💬
|
353 | Diacerein | 1件: Diacerein Diacerein | 1件: Diacerein
Diacerein
💬
| - | - | 2件: 36 36, 46 💬
|
354 | Diacerein 1% ointment | 1件: Diacerein Diacerein | 1件: Diacerein
Diacerein
💬
| - | - | 1件: 36 36 💬
|
355 | Diacerin cream | - | - | - | - | 1件: 36 36 💬
|
356 | Diacomit | 1件: Stiripentol Stiripentol | 1件: Stiripentol
Stiripentol
💬
| - | - | 1件: 140 140 💬
|
357 | Diagnosis OF fabry disease | - | - | - | - | 1件: 19 19 💬
|
358 | Diagnostic imaging | - | - | - | - | 1件: 60 60 💬
|
359 | Diagnostic laboratory biomarker analysis | - | - | - | - | 1件: 74 74 💬
|
360 | Diagnostic test | - | - | - | - | 1件: 265 265 💬
|
361 | Diammonium glycyrrhizinate enteric-coated capsule | - | - | - | - | 1件: 63 63 💬
|
362 | Diamox | - | - | - | - | 1件: 230 230 💬
|
363 | Diary completion | - | - | - | - | 1件: 6 6 💬
|
364 | Diazepam | 1件: Diazepam Diazepam | 1件: Diazepam
Diazepam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 155 155, 298 💬
|
365 | Diazepam, melatonin | 1件: Diazepam Diazepam | 1件: Diazepam
Diazepam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 46 46 💬
|
366 | Diazoxide | 1件: Diazoxide Diazoxide | 2件: Diazoxide
Diazoxide
,
Diazoxide choline
💬
| 2件: ABCC8 ABCC8, KCNJ11 💬
| 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 13 13 💬
|
367 | Diazoxide choline | 1件: Diazoxide Diazoxide | 2件: Diazoxide
Diazoxide
,
Diazoxide choline
💬
| 2件: ABCC8 ABCC8, KCNJ11 💬
| 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 💬
|
368 | Diazoxide choline controlled-release tablet | 1件: Diazoxide Diazoxide | 2件: Diazoxide
Diazoxide
,
Diazoxide choline
💬
| 2件: ABCC8 ABCC8, KCNJ11 💬
| 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 💬
|
369 | Dibase | - | - | - | - | 1件: 13 13 💬
|
370 | Dibase*IM OS 2F 1ML 300000UI/M | - | - | - | - | 1件: 46 46 💬
|
371 | Dichloroacetate | 1件: Dichloroacetic acid Dichloroacetic acid | 1件: Sodium dichloroacetate
Sodium dichloroacetate
💬
| 3件: PDK2_3_4 PDK2_3_4, PDK2_3_4, PDK2_3_4 💬
| 1件: Diabetic cardiomyopathy Diabetic cardiomyopathy 💬 | 1件: 21 21 💬
|
372 | Dichloroacetate sodium | 2件: Dichloroacetic acid Dichloroacetic acid, Sodium dichloroacetate | 1件: Sodium dichloroacetate
Sodium dichloroacetate
💬
| 3件: PDK2_3_4 PDK2_3_4, PDK2_3_4, PDK2_3_4 💬
| 1件: Diabetic cardiomyopathy Diabetic cardiomyopathy 💬 | 1件: 86 86 💬
|
373 | Dichlorphenamide | 1件: Diclofenamide Diclofenamide | 1件: Dichlorphenamide
Dichlorphenamide
💬
| 13件: CA CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA2, CA4 💬
| 6件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 114 114 💬
|
374 | Diclofenac | 1件: Diclofenac Diclofenac | 5件: Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 46 46, 271 💬
|
375 | Diclofenac + omeprazole | 1件: Diclofenac Diclofenac | 5件: Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
376 | Diclofenac 50 milligrams | 1件: Diclofenac Diclofenac | 5件: Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
377 | Diclofenac sodium | 1件: Diclofenac Diclofenac | 5件: Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 34 34, 46 💬
|
378 | Diclofenac sodium topical GEL | 1件: Diclofenac Diclofenac | 5件: Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
379 | Diclofenac SR | 1件: Diclofenac Diclofenac | 5件: Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
380 | Diclophenac | - | - | - | - | 1件: 271 271 💬
|
381 | Dicloxacillin | 1件: Dicloxacillin Dicloxacillin | 2件: Dicloxacillin sodium
Dicloxacillin sodium
,
Dicloxacillin
💬
| - | - | 1件: 299 299 💬
|
382 | Dicynone | - | - | - | - | 1件: 227 227 💬
|
383 | Didanosine | 1件: Didanosine Didanosine | 1件: Didanosine
Didanosine
💬
| - | - | 2件: 25 25, 265 💬
|
384 | Diet 1 | - | - | - | - | 2件: 96 96, 97 💬
|
385 | Diet 2 | - | - | - | - | 2件: 96 96, 97 💬
|
386 | Diet A group | - | - | - | - | 1件: 85 85 💬
|
387 | Diet and water adjustment | - | - | - | - | 1件: 67 67 💬
|
388 | Diet B group | - | - | - | - | 1件: 85 85 💬
|
389 | Diet C group | - | - | - | - | 1件: 85 85 💬
|
390 | Diet treatment | - | - | - | - | 1件: 240 240 💬
|
391 | Dietanolamina DE treprostinilo | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
392 | Dietary assignment | - | - | - | - | 1件: 95 95 💬
|
393 | Dietary counseling | - | - | - | - | 1件: 46 46 💬
|
394 | Dietary fiber mixture | - | - | - | - | 1件: 97 97 💬
|
395 | Dietary fiber supplementation | - | - | - | - | 1件: 46 46 💬
|
396 | Dietary guidance | - | - | - | - | 1件: 46 46 💬
|
397 | Dietary intervention with NO-carrageenan diet | - | - | - | - | 1件: 97 97 💬
|
398 | Dietary methionine tracer and protein intake | - | - | - | - | 1件: 337 337 💬
|
399 | Dietary pattern | - | - | - | - | 1件: 46 46 💬
|
400 | Dietary patterns | - | - | - | - | 1件: 46 46 💬
|
401 | Dietary recommendations | - | - | - | - | 2件: 46 46, 51 💬
|
402 | Dietary supplement FOR PKU patients | - | - | - | - | 1件: 240 240 💬
|
403 | Dietary supplement omega3 fatty acids aand vitamins | - | - | - | - | 1件: 46 46 💬
|
404 | Dietary therapy | - | - | - | - | 2件: 96 96, 97 💬
|
405 | Diethyl-[6-(4-hydroxycarbamoyl- phenyl carbamoyloxymethyl)-naphthalen-2-YL methyl]-ammonium chloride | - | - | - | - | 1件: 107 107 💬
|
406 | Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride MON | - | - | - | - | 1件: 96 96 💬
|
407 | Diethyldithiocarbamate | 1件: Ditiocarb Ditiocarb | - | - | - | 1件: 169 169 💬
|
408 | Dietician designed diet | - | - | - | - | 1件: 96 96 💬
|
409 | Difenidramina cloridrato | - | - | - | - | 3件: 11 11, 19, 63 💬
|
410 | Different diets | - | - | - | - | 1件: 6 6 💬
|
411 | Different haart regimens | - | - | - | - | 1件: 265 265 💬
|
412 | Dificlir 200 MG compresse rivestite CON film | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
413 | Dificlir 200 MG FILM-coated tablets | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
414 | Diflucan | 1件: Fluconazole Fluconazole | 1件: Fluconazole
Fluconazole
💬
| - | - | 1件: 96 96 💬
|
415 | Diflunisal | 1件: Diflunisal Diflunisal | 1件: Diflunisal
Diflunisal
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 28 28 💬
|
416 | Digestible maltodextrin | - | - | - | - | 1件: 96 96 💬
|
417 | Digipark monitor | - | - | - | - | 1件: 6 6 💬
|
418 | Digital lung sounds auscultation | - | - | - | - | 1件: 85 85 💬
|
419 | Digital recording OF speech and swallow sounds using THE beiwe digital health APP ON A personal smartphone | - | - | - | - | 1件: 2 2 💬
|
420 | Digitoxin | 1件: Digitoxin Digitoxin | 1件: Digitoxin
Digitoxin
💬
| 4件: ATP1A ATP1A, ATP1A, ATP1A, ATP1A 💬
| 19件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬
|
421 | Digna P144 cream | - | - | - | - | 1件: 51 51 💬
|
422 | Digoxin | 1件: Digoxin Digoxin | 1件: Digoxin
Digoxin
💬
| 4件: ATP1A ATP1A, ATP1A, ATP1A, ATP1A 💬
| 19件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 8 8, 46, 210 💬
|
423 | Digoxin 0.25 MG | 1件: Digoxin Digoxin | 1件: Digoxin
Digoxin
💬
| 4件: ATP1A ATP1A, ATP1A, ATP1A, ATP1A 💬
| 19件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬
|
424 | Dihuang | 1件: Rehmannia glutinosa root Rehmannia glutinosa root | 1件: Rehmannia root
Rehmannia root
💬
| - | - | 2件: 46 46, 66 💬
|
425 | Dihydroartemisinin tablet | 1件: Artenimol Artenimol | 1件: Artenimol
Artenimol
💬
| - | - | 1件: 49 49 💬
|
426 | Dihydroergot mesylate | - | - | - | - | 1件: 6 6 💬
|
427 | Dihydroergotine mesylate sustained-release tablets | - | - | - | - | 1件: 6 6 💬
|
428 | Dihydroergotoxine mesylate | 2件: Dihydroergotoxine Dihydroergotoxine, Ergoloid mesylate | 2件: Ergoloid mesylates
Ergoloid mesylates
,
Dihydroergotoxine
💬
| 6件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
429 | Dilatrend | - | - | - | - | 1件: 113 113 💬
|
430 | Diltiazem | 1件: Diltiazem Diltiazem | 3件: Diltiazem hydrochloride
Diltiazem hydrochloride
,
Diltiazem malate
,
Diltiazem
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 58, 88 💬
|
431 | Diltiazem hydrochloride | 1件: Diltiazem Diltiazem | 3件: Diltiazem hydrochloride
Diltiazem hydrochloride
,
Diltiazem malate
,
Diltiazem
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
432 | Diluent | - | - | - | - | 1件: 2 2 💬
|
433 | Dimebon | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
434 | Dimebon + dextromethorphan | 2件: Dextromethorphan Dextromethorphan, Latrepirdine | 5件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
,
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 7件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
435 | Dimebon + ketoconazole | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
436 | Dimebon + omeprazole | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
437 | Dimebon alone | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
438 | Dimebon dihydrochloride | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
439 | Dimebon IR | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
440 | Dimebon IR tablet | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
441 | Dimebon MR1 | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
442 | Dimebon MR2 | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
443 | Dimebon MR3 | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
444 | Dimebon MR4 | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
445 | Dimebon transdermal | 1件: Latrepirdine Latrepirdine | 2件: Latrepirdine
Latrepirdine
,
Latrepirdine dihydrochloride
💬
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬
|
446 | Dimebutic acid | 1件: 2,2-Dimethylbutyrate 2,2-Dimethylbutyrate | - | - | - | 2件: 245 245, 246 💬
|
447 | Dimension | 1件: Dithiopyr Dithiopyr | - | - | - | 1件: 55 55 💬
|
448 | Dimethyl fumarate | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 5件: 13 13, 20, 51, 86, 296 💬
|
449 | Dimethyl fumarate 240 MG | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
450 | Dimethyl sulfoxide | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | 1件: 226 226 💬
|
451 | Dimethylfumarat | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 49 49 💬
|
452 | Dimetil-fumarato | - | - | - | - | 1件: 13 13 💬
|
453 | Dimetilfumarato | - | - | - | - | 1件: 13 13 💬
|
454 | Dimeythl fumarate | - | - | - | - | 1件: 46 46 💬
|
455 | DIMS0150 | - | - | - | - | 1件: 97 97 💬
|
456 | Diode laser 980NM&100 mwatt | - | - | - | - | 1件: 56 56 💬
|
457 | Diosmin | 1件: Diosmin Diosmin | 1件: Diosmin
Diosmin
💬
| - | - | 3件: 51 51, 97, 265 💬
|
458 | Diosmin and hesperidin combination | 1件: Diosmin Diosmin | 1件: Diosmin
Diosmin
💬
| - | - | 1件: 46 46 💬
|
459 | Diosminex, 500 MG, tabletki powlekane | - | - | - | - | 1件: 265 265 💬
|
460 | Diovan 160 MG | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
461 | Diovan 40 MG | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
462 | Diovan 80 MG | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
463 | Diphenhydramine | 1件: Diphenhydramine Diphenhydramine | 4件: Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 10件: 13 13, 19, 49, 51, 70, 86, 96, 222, 256, 300 💬
|
464 | Diphenhydramine hydrochloride | 1件: Diphenhydramine Diphenhydramine | 4件: Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 11 11, 49 💬
|
465 | Diphenhydramine IV | 1件: Diphenhydramine Diphenhydramine | 4件: Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
466 | Diphenydramine | - | - | - | - | 1件: 13 13 💬
|
467 | Diphtheria booster vaccination | - | - | - | - | 1件: 97 97 💬
|
468 | Diphtheria toxoid | 1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | 1件: Diphtheria toxoid
Diphtheria toxoid
💬
| - | - | 2件: 13 13, 46 💬
|
469 | Dipivefrin | 1件: Dipivefrin Dipivefrin | 2件: Dipivefrin hydrochloride
Dipivefrin hydrochloride
,
Dipivefrin
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
470 | Dipivefrine | 1件: Dipivefrin Dipivefrin | 2件: Dipivefrin hydrochloride
Dipivefrin hydrochloride
,
Dipivefrin
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
471 | Diponecaftor | - | - | - | - | 1件: 299 299 💬
|
472 | Dipotassium salt | - | - | - | - | 1件: 46 46 💬
|
473 | Dipraglurant | 1件: Dipraglurant Dipraglurant | - | - | - | 1件: 6 6 💬
|
474 | Diprofos depot | - | - | - | - | 1件: 46 46 💬
|
475 | Dipyridamole | 1件: Dipyridamole Dipyridamole | 1件: Dipyridamole
Dipyridamole
💬
| 2件: PDE4 PDE4, PDE5 💬
| 5件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 46 46, 51, 66, 96 💬
|
476 | Dipyridamole and amoxapine | 1件: Dipyridamole Dipyridamole | 1件: Dipyridamole
Dipyridamole
💬
| 2件: PDE4 PDE4, PDE5 💬
| 5件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬
|
477 | Dipyridamole TAB 25 MG | 1件: Dipyridamole Dipyridamole | 1件: Dipyridamole
Dipyridamole
💬
| 2件: PDE4 PDE4, PDE5 💬
| 5件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 224 224 💬
|
478 | Diquafosol | 1件: Diquafosol Diquafosol | 1件: Diquafosol tetrasodium
Diquafosol tetrasodium
💬
| 1件: P2RY2 P2RY2 💬
| 4件: Efferocytosis Efferocytosis, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 53 53 💬
|
479 | Direct intravenous injection OF IVLV-X1 lentiviral vector | - | - | - | - | 1件: 65 65 💬
|
480 | Direct puncture repair / ethanol | - | - | - | - | 1件: 279 279 💬
|
481 | Direct puncture repair / polidocanol | - | - | - | - | 1件: 279 279 💬
|
482 | Direct surgery FOR acromegaly | - | - | - | - | 1件: 77 77 💬
|
483 | Diroximel fumarate | 1件: Diroximel fumarate Diroximel fumarate | 1件: Diroximel fumarate
Diroximel fumarate
💬
| - | - | 1件: 13 13 💬
|
484 | Dirucotide | 1件: Dirucotide Dirucotide | 1件: Dirucotide
Dirucotide
💬
| - | - | 1件: 13 13 💬
|
485 | Dirucotide acetate | 1件: Dirucotide Dirucotide | 1件: Dirucotide
Dirucotide
💬
| - | - | 1件: 13 13 💬
|
486 | Disability evaluation tests | - | - | - | - | 1件: 13 13 💬
|
487 | DISC-1459 | - | - | - | - | 1件: 254 254 💬
|
488 | Discontinuation OF disease modifying therapy | - | - | - | - | 1件: 13 13 💬
|
489 | Disease modified antirheumatic drugs or biological agents | - | - | - | - | 1件: 46 46 💬
|
490 | Disease modifying therapy | - | - | - | - | 1件: 13 13 💬
|
491 | Disease modifying treatments | - | - | - | - | 1件: 3 3 💬
|
492 | Disease-modifying ANTI-rheumatic drugs | - | - | - | - | 1件: 46 46 💬
|
493 | Disease-modifying antirheumatic drug | - | - | - | - | 1件: 46 46 💬
|
494 | Disodium citrate | - | - | - | - | 1件: 245 245 💬
|
495 | Disodium pyrophosphate | - | - | - | - | 1件: 166 166 💬
|
496 | Disodiumpyrophosphate | - | - | - | - | 1件: 166 166 💬
|
497 | Ditropan elixir | 1件: Oxybutynin Oxybutynin | 2件: Oxybutynin
Oxybutynin
,
Oxybutynin chloride
💬
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
498 | Diuretics (plus antiarrhythmic drugs, I.E. amiodarone, IN case OF complex ventricular arrhythmias) plus egcg | - | - | - | - | 1件: 28 28 💬
|
499 | Diuretics, aceis/arbs, beta blockers, positive inotropic drugs, mras, SGLT2I, retinoids | - | - | - | - | 2件: 58 58, 59 💬
|
500 | Diurf-006 | - | - | - | - | 1件: 81 81 💬
|
501 | Divalproex | - | - | - | - | 1件: 8 8 💬
|
502 | Divalproex sodium | - | - | - | - | 1件: 51 51 💬
|
503 | Divozilimab | 1件: Divozilimab Divozilimab | 1件: Divozilimab
Divozilimab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 51 💬
|
504 | DLX105 | - | - | - | - | 1件: 96 96 💬
|
505 | DM-1992 | - | - | - | - | 1件: 6 6 💬
|
506 | DM1-activc | - | - | - | - | 1件: 113 113 💬
|
507 | Dmard | - | - | - | - | 1件: 46 46 💬
|
508 | Dmard cessation | - | - | - | - | 1件: 46 46 💬
|
509 | Dmard maintenance | - | - | - | - | 1件: 46 46 💬
|
510 | Dmard therapy | - | - | - | - | 1件: 46 46 💬
|
511 | Dmards | - | - | - | - | 2件: 46 46, 271 💬
|
512 | Dmards (methotrexate | - | - | - | - | 1件: 46 46 💬
|
513 | Dmards or biologics | - | - | - | - | 1件: 46 46 💬
|
514 | Dmps | 1件: 2,3-Dimercapto-1-propanesulfonic acid 2,3-Dimercapto-1-propanesulfonic acid | - | - | - | 1件: 171 171 💬
|
515 | Dmsa | 1件: Succimer Succimer | 1件: Succimer
Succimer
💬
| - | - | 1件: 171 171 💬
|
516 | Dmso | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | 1件: 226 226 💬
|
517 | Dmso cocktail | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: Dimethyl sulfoxide
Dimethyl sulfoxide
💬
| - | - | 1件: 226 226 💬
|
518 | DMT | - | - | - | - | 1件: 13 13 💬
|
519 | DMT category 1 | - | - | - | - | 1件: 13 13 💬
|
520 | DMT continuation | - | - | - | - | 1件: 13 13 💬
|
521 | DMT withdrawal | - | - | - | - | 1件: 13 13 💬
|
522 | DMX-200 | - | - | - | - | 1件: 222 222 💬
|
523 | DNA analysis | - | - | - | - | 3件: 6 6, 28, 60 💬
|
524 | DNA BIO-banking | - | - | - | - | 1件: 122 122 💬
|
525 | DNA sequencing | - | - | - | - | 1件: 85 85 💬
|
526 | DNA/genetictesting | - | - | - | - | 1件: 6 6 💬
|
527 | Dnaj peptide | - | - | - | - | 1件: 46 46 💬
|
528 | DNL126 | - | - | - | - | 1件: 19 19 💬
|
529 | DNL151 | - | - | - | - | 1件: 6 6 💬
|
530 | DNL151, DN0001575, DN1575 | - | - | - | - | 1件: 6 6 💬
|
531 | DNL201 | - | - | - | - | 1件: 6 6 💬
|
532 | DNL310 drug substance | - | - | - | - | 1件: 19 19 💬
|
533 | DNL343 | 1件: DNL343 DNL343 | - | - | - | 1件: 2 2 💬
|
534 | DNL593 | - | - | - | - | 1件: 127 127 💬
|
535 | DNL593 sterile lyophilisate | - | - | - | - | 1件: 127 127 💬
|
536 | DNL747 | - | - | - | - | 1件: 2 2 💬
|
537 | DNTH103 | - | - | - | - | 2件: 11 11, 14 💬
|
538 | Dobutamin | 1件: Dobutamine Dobutamine | 3件: Dobutamine hydrochloride
Dobutamine hydrochloride
,
Dobutamine
,
Dobutamine tartrate
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 215 215 💬
|
539 | Dobutamine | 1件: Dobutamine Dobutamine | 3件: Dobutamine hydrochloride
Dobutamine hydrochloride
,
Dobutamine
,
Dobutamine tartrate
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 57 57, 58, 215 💬
|
540 | Dobutamine test | 1件: Dobutamine Dobutamine | 3件: Dobutamine hydrochloride
Dobutamine hydrochloride
,
Dobutamine
,
Dobutamine tartrate
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
541 | Docosahexaenoic acid | 1件: Doconexent Doconexent | - | - | - | 6件: 6 6, 49, 90, 94, 240, 299 💬
|
542 | Docosahexaenoic acid (DHA) dietary supplement | 1件: Doconexent Doconexent | - | - | - | 1件: 301 301 💬
|
543 | Docosahexaenoic acid administration: 50 MG/KG/DAY during 12 months | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 💬
|
544 | Docosahexanoic acid supplement | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 💬
|
545 | Dolasetron | 1件: Dolasetron Dolasetron | 2件: Dolasetron mesylate
Dolasetron mesylate
,
Dolasetron
💬
| 5件: HTR3 HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 46 46 💬
|
546 | Dolobid | 1件: Diflunisal Diflunisal | 1件: Diflunisal
Diflunisal
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 28 28 💬
|
547 | Dolquine | - | - | - | - | 1件: 46 46 💬
|
548 | Dolutegravir | 1件: Dolutegravir Dolutegravir | 2件: Dolutegravir
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | 2件: 2 2, 265 💬
|
549 | Dolutegravir / lamivudine oral tablet | 1件: Dolutegravir Dolutegravir | 2件: Dolutegravir
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | 1件: 265 265 💬
|
550 | Dolutegravir 50 MG | 1件: Dolutegravir Dolutegravir | 2件: Dolutegravir
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | 1件: 265 265 💬
|
551 | Dolutegravir, abacavir and lamivudine | 1件: Dolutegravir Dolutegravir | 2件: Dolutegravir
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | 1件: 2 2 💬
|
552 | Domperidone | 1件: Domperidone Domperidone | 2件: Domperidone
Domperidone
,
Domperidone maleate
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 💬
|
553 | Dompéridone | - | - | - | - | 1件: 6 6 💬
|
554 | Donepezil | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 8件: 5 5, 6, 13, 46, 124, 127, 156, 206 💬
|
555 | Donepezil hydrochloride | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 3件: 6 6, 124, 156 💬
|
556 | Donepezil sandoz | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
557 | Donidalorsen | 1件: Donidalorsen Donidalorsen | - | - | - | 1件: 65 65 💬
|
558 | Donor derived G-CSF mobilized PBC | - | - | - | - | 1件: 60 60 💬
|
559 | Donor lymphocyte infusion | - | - | - | - | 1件: 60 60 💬
|
560 | Donor lymphocytes | - | - | - | - | 1件: 28 28 💬
|
561 | Donor mesenchymal stem cell infusions | - | - | - | - | 1件: 36 36 💬
|
562 | Donor mobilized pbsc infusion | - | - | - | - | 3件: 60 60, 65, 285 💬
|
563 | Dopafuse delivery system | - | - | - | - | 1件: 6 6 💬
|
564 | Dopamine | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 7, 77 💬
|
565 | Dopamine agent | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
566 | Dopamine agonist treatment | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 74 74 💬
|
567 | Dopamine agonists | 1件: Dopamine Dopamine | 2件: Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 74 74 💬
|
568 | Dopaminergic agonist + apomorphine | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
569 | Dopaminergic agonists | - | - | - | - | 1件: 6 6 💬
|
570 | Dopaminergic medication | - | - | - | - | 1件: 6 6 💬
|
571 | Dopastatin | 1件: Dopastatin Dopastatin | - | - | - | 1件: 77 77 💬
|
572 | Doppler ultrasound | - | - | - | - | 1件: 49 49 💬
|
573 | Doptelet 20 MG FILM-coated tablets | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
574 | Doravirine | 1件: Doravirine Doravirine | 1件: Doravirine
Doravirine
💬
| - | - | 1件: 265 265 💬
|
575 | Doribax | 1件: Doripenem Doripenem | 2件: Doripenem hydrate
Doripenem hydrate
,
Doripenem
💬
| - | - | 1件: 299 299 💬
|
576 | Doripenem hydrate | 1件: Doripenem Doripenem | 2件: Doripenem hydrate
Doripenem hydrate
,
Doripenem
💬
| - | - | 1件: 299 299 💬
|
577 | Dornase alfa | 1件: Dornase alfa Dornase alfa | 1件: Dornase alfa
Dornase alfa
💬
| - | - | 2件: 53 53, 299 💬
|
578 | Dornase alpha | 1件: Dornase alfa Dornase alfa | 1件: Dornase alfa
Dornase alfa
💬
| - | - | 1件: 299 299 💬
|
579 | Dorzolamide | 1件: Dorzolamide Dorzolamide | 2件: Dorzolamide hydrochloride
Dorzolamide hydrochloride
,
Dorzolamide
💬
| 13件: CA CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA2, CA4 💬
| 6件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 90 90 💬
|
580 | Dosage OF cytokines | - | - | - | - | 1件: 50 50 💬
|
581 | Dosage OF delta-aminolevulinic acid and porphobilinogen | - | - | - | - | 1件: 254 254 💬
|
582 | Dosage OF serotonin and metabolites | - | - | - | - | 1件: 164 164 💬
|
583 | Dose | - | - | - | - | 1件: 98 98 💬
|
584 | Dose 1 OF BMN 331 | - | - | - | - | 1件: 65 65 💬
|
585 | Dose 2 OF BMN 331 | - | - | - | - | 1件: 65 65 💬
|
586 | Dose 3 OF BMN 331 | - | - | - | - | 1件: 65 65 💬
|
587 | Dose 4 OF BMN 331 | - | - | - | - | 1件: 65 65 💬
|
588 | Dose 5 OF BMN 331 | - | - | - | - | 1件: 65 65 💬
|
589 | Dose 6 OF BMN 331 | - | - | - | - | 1件: 65 65 💬
|
590 | Dose 7 OF BMN 331 | - | - | - | - | 1件: 65 65 💬
|
591 | Dose A KER-012 | - | - | - | - | 1件: 86 86 💬
|
592 | Dose B KER-012 | - | - | - | - | 1件: 86 86 💬
|
593 | Dose C KER-012 | - | - | - | - | 1件: 86 86 💬
|
594 | Dose level 1 | - | - | - | - | 1件: 46 46 💬
|
595 | Dose level 2 | - | - | - | - | 1件: 46 46 💬
|
596 | Dose level 3 | - | - | - | - | 1件: 46 46 💬
|
597 | Dose level 4 | - | - | - | - | 1件: 46 46 💬
|
598 | Dose OF 60 MG/KG alpha1-proteinase inhibitor | - | - | - | - | 1件: 231 231 💬
|
599 | Dose OF 60 MG/KG fraction IV-1 alpha1-proteinase inhibitor | - | - | - | - | 1件: 231 231 💬
|
600 | Dose reduction TO 2MG/L | - | - | - | - | 1件: 46 46 💬
|
601 | Dose reduction TO 5MG/L | - | - | - | - | 1件: 46 46 💬
|
602 | Dosing extension | - | - | - | - | 1件: 113 113 💬
|
603 | Dosing interruption OF natalizumab | - | - | - | - | 1件: 13 13 💬
|
604 | Dostinex | 1件: Cabergoline Cabergoline | 1件: Cabergoline
Cabergoline
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 75 75, 77 💬
|
605 | Dostinex 0,5 MG tabletten | - | - | - | - | 1件: 77 77 💬
|
606 | Dostinex 0.5MG tabletts | 1件: Cabergoline Cabergoline | 1件: Cabergoline
Cabergoline
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
607 | Dostinex 2CPR 0,5MG | 1件: Cabergoline Cabergoline | 1件: Cabergoline
Cabergoline
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
608 | Dotanoc | - | - | - | - | 1件: 84 84 💬
|
609 | Dotatate PET-CT | 1件: Dotatate Dotatate | - | - | - | 1件: 75 75 💬
|
610 | Double dose | - | - | - | - | 2件: 38 38, 162 💬
|
611 | Double-blind abatacept | - | - | - | - | 1件: 46 46 💬
|
612 | Double-blind adalimumab | - | - | - | - | 2件: 46 46, 107 💬
|
613 | Double-blind rituximab | - | - | - | - | 1件: 51 51 💬
|
614 | Doxazosin | 1件: Doxazosin Doxazosin | 2件: Doxazosin mesylate
Doxazosin mesylate
,
Doxazosin
💬
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 67 67 💬
|
615 | Doxepin and zopiclone | 1件: Doxepin Doxepin | 2件: Doxepin hydrochloride
Doxepin hydrochloride
,
Doxepin
💬
| 3件: HRH1 HRH1, SLC6A2, SLC6A4 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
616 | Doxiciclina | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 28 28 💬
|
617 | Doxil | - | - | - | - | 1件: 63 63 💬
|
618 | Doxorubicin | 1件: Doxorubicin Doxorubicin | 2件: Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | 3件: 26 26, 28, 331 💬
|
619 | Doxorubicin hydrochloride | 1件: Doxorubicin Doxorubicin | 2件: Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | 3件: 26 26, 34, 331 💬
|
620 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase | 1件: Doxorubicin Doxorubicin | 2件: Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | 1件: 65 65 💬
|
621 | Doxycyclin | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 299 299 💬
|
622 | Doxycycline | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 13件: 23 23, 28, 34, 46, 84, 89, 96, 97, 158, 161, 162, 280, 299 💬
|
623 | Doxycycline 100 MG capsules | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 89 89 💬
|
624 | Doxycycline 100-200MG capsules daily FOR 6 months | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 167 167 💬
|
625 | Doxycycline hyclate | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 3件: 23 23, 96, 227 💬
|
626 | Doxycycline hyclate PH.EUR | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 167 167 💬
|
627 | Doxycycline tablets | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 46 46 💬
|
628 | Doxyhexal® tabs 100 MG tabletten | - | - | - | - | 1件: 28 28 💬
|
629 | DP mannitol | 1件: Mannitol Mannitol | 1件: Mannitol
Mannitol
💬
| - | - | 1件: 299 299 💬
|
630 | DPA | - | - | - | - | 4件: 2 2, 6, 13, 127 💬
|
631 | DPA-714 metabolite analysis | - | - | - | - | 1件: 6 6 💬
|
632 | DPA-714 PET/MRI | - | - | - | - | 1件: 13 13 💬
|
633 | Dppg | - | - | - | - | 1件: 79 79 💬
|
634 | DR-0201 | - | - | - | - | 3件: 50 50, 51, 53 💬
|
635 | DR. reddy’S rituximab (drl_ri) 100MG | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
636 | DR. reddy’S rituximab (drl_ri) 500MG | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
637 | DRF | - | - | - | - | 1件: 13 13 💬
|
638 | Dried blood spot (DBS) sampling | - | - | - | - | 1件: 19 19 💬
|
639 | Dried chicory root | - | - | - | - | 1件: 97 97 💬
|
640 | Drisapersen | 1件: Drisapersen Drisapersen | 1件: Drisapersen
Drisapersen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
641 | Drisapersen sodium | 1件: Drisapersen Drisapersen | 1件: Drisapersen
Drisapersen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
642 | Drl_ri | - | - | - | - | 1件: 46 46 💬
|
643 | Dronabinol | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 2 2, 13, 298 💬
|
644 | Dronabinol 25 MG/ML, oral drops | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
645 | Dronabinol capsule 2,5 MG | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
646 | Dronabinol capsule 2.5. MG | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 46 46, 271 💬
|
647 | Droxidopa | 1件: Droxidopa Droxidopa | 1件: Droxidopa
Droxidopa
💬
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬
| 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 💬
|
648 | Drug - SHR1459 | - | - | - | - | 1件: 13 13 💬
|
649 | Drug free | - | - | - | - | 1件: 49 49 💬
|
650 | Drug free, IS monotherapy and GC combined with IS | - | - | - | - | 1件: 300 300 💬
|
651 | Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom | - | - | - | - | 2件: 46 46, 49 💬
|
652 | Drug protocol | - | - | - | - | 1件: 46 46 💬
|
653 | DRX005B | - | - | - | - | 1件: 19 19 💬
|
654 | DRY powder inhaler | - | - | - | - | 1件: 85 85 💬
|
655 | DRY powder tobramycin | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
656 | DS-1211B | - | - | - | - | 1件: 166 166 💬
|
657 | DS-2325A | 1件: DS-2325a DS-2325a | - | - | - | 1件: 160 160 💬
|
658 | DS-5141B | - | - | - | - | 1件: 113 113 💬
|
659 | DS-7011A | - | - | - | - | 1件: 49 49 💬
|
660 | DSG3-caart or CABA-201 | - | - | - | - | 1件: 35 35 💬
|
661 | DSP-3077 retinal sheet cohort 1 | - | - | - | - | 1件: 90 90 💬
|
662 | DSP-3077 retinal sheet cohort 2 | - | - | - | - | 1件: 90 90 💬
|
663 | DSP-3077 retinal sheet cohort 3 | - | - | - | - | 1件: 90 90 💬
|
664 | DSP-9632P 27.5 MG | - | - | - | - | 1件: 6 6 💬
|
665 | DSP-9632P 55.0 MG | - | - | - | - | 1件: 6 6 💬
|
666 | DSP-9632P 82.5 MG | - | - | - | - | 1件: 6 6 💬
|
667 | DT-216 | - | - | - | - | 1件: 18 18 💬
|
668 | DT-216p2 | - | - | - | - | 1件: 18 18 💬
|
669 | DT-DEC01 | 1件: DT-DEC01 DT-DEC01 | - | - | - | 1件: 113 113 💬
|
670 | DTX301 | 1件: Avalotcagene ontaparvovec Avalotcagene ontaparvovec | - | - | - | 1件: 251 251 💬
|
671 | Dual AAV8.MYO7A | - | - | - | - | 2件: 90 90, 303 💬
|
672 | Dual biological therapy | - | - | - | - | 1件: 97 97 💬
|
673 | Dual task performance | - | - | - | - | 1件: 13 13 💬
|
674 | DUAL-therapy | - | - | - | - | 1件: 50 50 💬
|
675 | Duchenne muscular dystrophy group with deflazacort | - | - | - | - | 1件: 113 113 💬
|
676 | Duchenne muscular dystrophy group with prednisone/predisolone | - | - | - | - | 1件: 113 113 💬
|
677 | Duchenne muscular dystrophy group without corticosteroids therapy | - | - | - | - | 1件: 113 113 💬
|
678 | Ducressa | - | - | - | - | 1件: 90 90 💬
|
679 | Dulaglutide 0.75MG/0.5ML INJ PEN | 1件: Dulaglutide Dulaglutide | 1件: Dulaglutide
Dulaglutide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
680 | Duloxetine | 1件: Duloxetine Duloxetine | 2件: Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 💬
|
681 | Duloxetine hydrochloride | 1件: Duloxetine Duloxetine | 2件: Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
682 | DUO-therapy with sildenafil + bosentan | - | - | - | - | 1件: 86 86 💬
|
683 | DUOC-01 | - | - | - | - | 3件: 13 13, 19, 20 💬
|
684 | Duodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
685 | Duodopa GEL intestinale | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
686 | Duodopa intestinal GEL | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
687 | Duodopa intestinalgel | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
688 | Duodopa LD/CD 20/5 MG/ML | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
689 | Duodopa, 20 MG/ML + 5 MG/ML, intestinal GEL | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
690 | Duodopa, levodopa 20 MG/ML + carbidopa 5 MG/ML, intestinal GEL | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
691 | Duodopa®intestinal GEL | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
692 | Dupilumab | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 5件: 51 51, 97, 98, 160, 162 💬
|
693 | Dupilumab 300MG solution FOR injection | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 51 51 💬
|
694 | Dupilumab injection | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 💬
|
695 | Dupilumab prefilled syringe | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 💬
|
696 | Dupixent | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 3件: 98 98, 160, 162 💬
|
697 | DUR-928 | - | - | - | - | 1件: 94 94 💬
|
698 | Duramycin | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 💬
|
699 | Duramycin, 2622u90 | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 💬
|
700 | Durvalumab | 1件: Durvalumab Durvalumab | 1件: Durvalumab
Durvalumab
💬
| 1件: PDL1 PDL1 💬
| 2件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | 1件: 85 85 💬
|
701 | Dusquetide | 1件: Dusquetide Dusquetide | 1件: Dusquetide
Dusquetide
💬
| - | - | 1件: 56 56 💬
|
702 | Dutasterida | 1件: Dutasteride Dutasteride | 1件: Dutasteride
Dutasteride
💬
| 2件: SRD5A1 SRD5A1, SRD5A2 💬
| 2件: Prostate cancer Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 2 2 💬
|
703 | Dutasteride | 1件: Dutasteride Dutasteride | 1件: Dutasteride
Dutasteride
💬
| 2件: SRD5A1 SRD5A1, SRD5A2 💬
| 2件: Prostate cancer Prostate cancer, Steroid hormone biosynthesis 💬 | 2件: 1 1, 2 💬
|
704 | Duvoglustat | 1件: Duvoglustat Duvoglustat | 2件: Duvoglustat
Duvoglustat
,
Duvoglustat hydrochloride
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
705 | Duvoglustat HCL | 1件: Duvoglustat Duvoglustat | 2件: Duvoglustat
Duvoglustat
,
Duvoglustat hydrochloride
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
706 | Duvoglustat hydrochloride | 1件: Duvoglustat Duvoglustat | 2件: Duvoglustat
Duvoglustat
,
Duvoglustat hydrochloride
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
707 | DW1809-1 | - | - | - | - | 1件: 46 46 💬
|
708 | DW1809-T2 | - | - | - | - | 1件: 46 46 💬
|
709 | DWN12088 | - | - | - | - | 1件: 85 85 💬
|
710 | DWP422 25MG | - | - | - | - | 1件: 46 46 💬
|
711 | DX-2930 | - | - | - | - | 1件: 65 65 💬
|
712 | DX-2930 - 150MG/4WK | - | - | - | - | 1件: 65 65 💬
|
713 | DX-2930 - 300MG/2WK | - | - | - | - | 1件: 65 65 💬
|
714 | DX-2930 - 300MG/4WK | - | - | - | - | 1件: 65 65 💬
|
715 | DX-88 | - | - | - | - | 1件: 65 65 💬
|
716 | DX-890 | 1件: Depelestat Depelestat | 1件: Depelestat
Depelestat
💬
| 1件: ELANE ELANE 💬
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | 1件: 299 299 💬
|
717 | DX2930 | - | - | - | - | 1件: 65 65 💬
|
718 | Dydrogesterone | 1件: Dydrogesterone Dydrogesterone | 1件: Dydrogesterone
Dydrogesterone
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
719 | DYN101 | 1件: DYN-101 DYN-101 | - | - | - | 1件: 111 111 💬
|
720 | Dynamic balance training | - | - | - | - | 1件: 13 13 💬
|
721 | Dynamic balance walking training | - | - | - | - | 1件: 13 13 💬
|
722 | Dynamic contrast-enhanced magnetic resonance imaging | - | - | - | - | 1件: 13 13 💬
|
723 | DYNE-101 | - | - | - | - | 1件: 113 113 💬
|
724 | DYNE-251 | 1件: DYNE-251 DYNE-251 | - | - | - | 1件: 113 113 💬
|
725 | Dyphenhydramine hydrochloride | - | - | - | - | 1件: 63 63 💬
|
726 | Dysport | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 13 13, 36 💬
|
727 | Dysport*SC IM 2FL 500U | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
728 | Dystrophin levels | - | - | - | - | 1件: 113 113 💬
|
729 | DYT 1 dystonia | - | - | - | - | 1件: 6 6 💬
|
730 | DZP | - | - | - | - | 1件: 49 49 💬
|
731 | Désogestrel | 1件: Desogestrel Desogestrel | 1件: Desogestrel
Desogestrel
💬
| 2件: ESR1 ESR1, PGR 💬
| 11件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 230 230 💬
|